Начало › Сърдечна недостатъчност › Тексас › Dallas
Клинични проучвания за Сърдечна недостатъчност в Dallas, TX
42 проучвания за Сърдечна недостатъчност търсят участници в обекти в и около Dallas (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
ELEVATE-HFpEF Clinical Study
Набиране на участници
- Dallas VA Medical Center, Dallas
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Набиране на участнициФаза 3
- Research Site, Dallas
- Research Site, Dallas
- Research Site, Dallas
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Набиране на участнициФаза 3
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Набиране на участнициФаза 3
- Texas Health Research and Education Institute, Dallas
- Southwest Family Medicine Associates, Dallas
- University of Texas Southwestern Medical Center, Dallas
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Набиране на участнициФаза 2
- University of Texas Southwestern Medical Center, Dallas
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
Набиране на участници
- University of Texas Southwestern Medical Center, Dallas
- Parkland Health & Hospital System (PHHS), Dallas
- Baylor Scott and White - Health System, Dallas
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Набиране на участнициФаза 3
- Research Site, Dallas
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Набиране на участнициФаза 3
- Baylor University Medical Center, Dallas
- The University of Texas Southwestern Medical Center, Dallas
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
Набиране на участници
- University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location, Dallas
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Набиране на участнициФаза 3
- Cedar Health Research, LLC, Dallas
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Набиране на участнициФаза 3
- Research Site, Dallas
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Набиране на участнициФаза 3
- Dallas, TX Investigative Site 10042, Dallas
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Набиране на участници
- Baylor University Medical Center, part of Baylor Scott & White Health, Dallas
- UT southwestern Medical Center, Dallas
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Набиране на участнициФаза 2
- Local Institution - 167, Dallas
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Набиране на участнициФаза 2/3
- Children's Health-The Heart Center ( Site 0015), Dallas
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Набиране на участнициФаза 2
- University of Texas Southwestern Medical Center, Dallas, Dallas
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Набиране на участнициНаблюдателно проучване
- Dallas, Dallas
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Набиране на участнициНаблюдателно проучване
- North Texas Cardiology Center, Dallas
- Baylor Scott & White Research Institute, Dallas
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Набиране на участнициФаза 3
- Tenax Investigational Site, Dallas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Набиране на участнициФаза 3
- Renal Disease Research Institute, Dallas
- Texas Health Heart and Vascular Specialists, Dallas
- Southwest Family Medicine_Dallas, Dallas
- и още 1
Alleviant ALLAY-HF Study
Набиране на участници
- UT Southwestern, Dallas
CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
Набиране на участници
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
Набиране на участнициНаблюдателно проучване
- Baylor University Medical Center, Dallas
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System
Набиране на участнициФаза 2
- Children's Health Dallas, Dallas
Assessment of CCM in HF With Higher Ejection Fraction
Набиране на участници
- Baylor Scott and White Research Institute, Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Набиране на участнициФаза 3
- Children's Medical Center Dallas - Cardiology, Dallas
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Набиране на участници
- Medical City Healthcare Dallas, Dallas
- Baylor Scott & White -Dallas, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Набиране на участнициФаза 3
- Children's Medical Center Dallas - Cardiology, Dallas
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Набиране на участници
- Baylor University Hospital, Dallas
Home-based Cardiac Rehabilitation in Heart Failure
Набиране на участнициФаза 3
- University of Texas Southwestern Medical Center, Dallas
- Baylor Scott and White Health System, Dallas
IEEM-Heat and Heart Failure
Набиране на участнициЗдравите доброволци са добре дошли
- Institute for Exercise and Environmental Medicine - Texas Health Presbyterian Hospital Dallas, Dallas
Using Ultromics EchoGo HFpEF Algorithm to Identify and Treat High Heart Failure Risk in Patients With Type 2 Diabetes
Набиране на участници
- UT Southwestern Medical Center, Dallas
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Набиране на участнициФаза 3
- University of Texas Southwestern, Dallas
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Набиране на участници
- University of Texas Southwestern Medical Center, Dallas
Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation
Набиране на участнициФаза 2
- UT Southwestern Medical Center, Dallas
Cardiopulmonary Stress Testing (CPET) AlloSure Study
Набиране на участнициНаблюдателно проучване
- Baylor Scott & White health research institute, Dallas
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
Набиране на участнициФаза 2
- Baylor University Medical Center, Dallas
Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
Набиране на участнициФаза 2/3
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Cardiogenic Shock Working Group Registry
Набиране на участнициНаблюдателно проучване
- Baylor Scott & White Advanced Heart Failure Clinic, Dallas
Get With The Guidelines-Heart Failure Registry
Набиране на участнициНаблюдателно проучванеЗдравите доброволци са добре дошли
- Amy Bennett, Dallas
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
Набиране на участнициНаблюдателно проучване
- UT Southwestern Medical Center, Dallas
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Набиране на участнициФаза 1/2
- University of Texas Southwestern Medical Center, Dallas
Проучвания за Сърдечна недостатъчност в други градове
- New York City, NY51 проучвания
- Boston, MA44 проучвания
- Houston, TX36 проучвания
- Cleveland, OH33 проучвания
- Chicago, IL31 проучвания
- Philadelphia, PA31 проучвания
- San Francisco, CA29 проучвания
- St. Louis, MO26 проучвания
- Durham, NC26 проучвания
- Kansas City, MO25 проучвания
- Atlanta, GA25 проучвания
- Baltimore, MD24 проучвания
Други проучвания в Dallas
- Рак на гърдата55 проучвания
- Рак на белия дроб с недребноклетъчен тип52 проучвания
- Метастатичен рак42 проучвания
- Рак (всички видове)37 проучвания
- Рак на простатата36 проучвания
- Колоректален рак33 проучвания
- Затлъстяване30 проучвания
- Рак на яйчниците28 проучвания
- Рак на пикочния мехур27 проучвания
- Рак на белия дроб27 проучвания
- Ендометриален рак24 проучвания
- Сърдечно-съдово заболяване23 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.